Search
for
Sort by
Research 121–150 of 1000+
- Insulin Resistance and Polycystic Ovary Syndrome
- Dermatoses of pregnancy
- Androgenetic alopecia: pathogenesis and potential for therapy
- An Update of Congenital Adrenal Hyperplasia
- Adverse health effects of androgen use
- Physiologic changes and dermatoses of pregnancy
- Pre-clinical non-viral vectors exploited for<i>in vivo</i>CRISPR/Cas9 gene editing: an overview
- The metabolic syndrome- associated small G protein ARL15 plays a role in adipocyte differentiation and adiponectin secretion
- Is polycystic ovary syndrome a sexual conflict? A review
- Metabolism and skin diseases
- The Relationship between Lichen Planus and Carotid Intima Media Thickness.
- Serum Cystatin C levels in adolescent females: A comparative study between PCOS and Non-PCOS groups
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- Multidisciplinary treatment of obesity with a protein-sparing modified fast: results in 668 outpatients.
- Current concepts in the pathogenesis and treatment of acne
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
- Polycystic ovary syndrome (PCOS)
- The skin and obesity
- Appearance and Internal Aging
- Polymorphisms in androgen and estrogen receptor genes: effects on male aging
- Women’s Health Considerations for Lipid Management
- Polycystic Ovarian Syndrome - A Pain for Young Women? An Autobiographical Case Studies
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence
- Beyond acne: Current aspects of sebaceous gland biology and function
- Hormonal Therapy for Acne
- What do we know about phytotherapy of benign prostatic hyperplasia?
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- How to diagnose a lipodystrophy syndrome
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- 5α-Reduced glucocorticoids: a story of natural selection